BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38256140)

  • 1. The TGF-β Family in Glioblastoma.
    Golán-Cancela I; Caja L
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
    Caja L; Bellomo C; Moustakas A
    FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
    Jiang X; Zhou T; Wang Z; Qi B; Xia H
    ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors for bone growth and repair: IGF, TGF beta and BMP.
    Linkhart TA; Mohan S; Baylink DJ
    Bone; 1996 Jul; 19(1 Suppl):1S-12S. PubMed ID: 8830994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tgf-Beta signaling in development.
    Kitisin K; Saha T; Blake T; Golestaneh N; Deng M; Kim C; Tang Y; Shetty K; Mishra B; Mishra L
    Sci STKE; 2007 Aug; 2007(399):cm1. PubMed ID: 17699101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
    Roy LO; Poirier MB; Fortin D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β links glycolysis and immunosuppression in glioblastoma.
    Gong L; Ji L; Xu D; Wang J; Zou J
    Histol Histopathol; 2021 Nov; 36(11):1111-1124. PubMed ID: 34323284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-3 facilitates the progression and mediates the tumorigenic effects of TGF-β in glioblastoma multiforme.
    Sun Z; Yan T; Jiang H; Cai J; Zhu X; Chen Q
    Med Oncol; 2023 Aug; 40(9):268. PubMed ID: 37578554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.
    Wick W; Naumann U; Weller M
    Curr Pharm Des; 2006; 12(3):341-9. PubMed ID: 16454748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.
    Birch JL; Coull BJ; Spender LC; Watt C; Willison A; Syed N; Chalmers AJ; Hossain-Ibrahim MK; Inman GJ
    Cell Signal; 2020 Aug; 72():109638. PubMed ID: 32320860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
    Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
    Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
    Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
    Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
    Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
    Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
    Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.